HIV Prevention and Treatment Clinical Trials Unit at UNC
Official title: University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit
Funded at Univ of North Carolina Chapel Hill · NIH-11458533 · Data updated 2026-11-12
A UNC-led program will run multiple HIV prevention and treatment trials across the US and other regions to improve care for people living with HIV and those at risk.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project start | December 1, 2025 |
| Project end | November 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $105,363 |
| NIH project number | 3UM1AI069423-20S1 |
| Project ID | NIH-11458533 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults and adolescents living with HIV or at risk for HIV infection, including individuals with acute infection, adherence challenges, or drug resistance, across multiple global sites.
✕Less likely to help
Participants not living with HIV and not at risk for HIV would be less likely to benefit directly.
What this research studies
This program coordinates clinical trial activities across four NIH networks to advance HIV prevention, treatment, and vaccine strategies. It involves several experienced investigators and multiple clinical research sites in the US, Malawi, and Vietnam, enrolling adults and children living with HIV or at risk for infection. The unit will work with participants including newly diagnosed individuals, those on stable therapy, and those facing adherence or drug-resistance challenges, while coordinating with sites that manage co-infections like TB and HBV. The effort aims to translate findings into improved standards of care and prevention in diverse settings.
Why it matters
Potential benefit: Could lead to better HIV prevention methods, more effective treatment options, and improved care for people living with HIV and those at risk.
How similar studies have gone: Previous large multicenter HIV trials have informed current prevention and treatment guidelines and show promise for similar approaches now.
Where this research is happening
-
Univ of North Carolina Chapel Hill
Chapel Hill, United States Active
Researchers
- Principal investigator: Eron, Joseph J — Univ of North Carolina Chapel Hill
- Study coordinator: Eron, Joseph J
Related research
Other NIH-funded projects on the same topics.
-
Making HIV prevention and care easier for Ugandan youth
A Ugandan study is testing ways to help adolescents and young adults (15–24) prevent HIV and stay healthy, using long-acting PrEP and youth-friendly services.
-
Innovative HIV Prevention and Care Interventions for Adolescents and Young Adults in Uganda
A Ugandan research team is testing practical, youth-focused strategies to help 15-24 year-olds using HIV prevention or treatment services stay healthy and engaged in care.
-
Adolescent girls in Uganda: a long-term look at how money empowerment and family support affect HIV prevention, care, and mental health
A long-term study in rural Uganda will test whether an intervention that combines economic empowerment and family strengthening can help HIV-negative and HIV-affected adolescent girls move safely into young adulthood.
-
Long-term HIV prevention and mental health support for adolescent girls and young women in Uganda
A long-term program in rural Uganda tests if combining economic support and family strengthening helps teenage girls stay HIV-free and improve mental health as they grow into young adults.
-
Harnessing male peer networks to boost HIV testing and PrEP use
A large clinical trial in South Africa tests whether giving HIV self-test kits through male peer networks, with phone support, increases PrEP uptake among men.
-
Harnessing men's peer networks to boost HIV self-testing and PrEP use
A large project in South Africa tests whether giving HIV self-test kits through men’s social networks, with phone support, can lead to more men starting PrEP and using HIV testing.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.